Tumor interaction with hemostasis: the rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer.
about
Acoustic driven flow and lattice Boltzmann simulations to study cell adhesion in biofunctionalized mu-fluidic channels with complex geometry.Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.The Arg-Gly-Asp-containing peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by saos-2 human osteosarcoma cellsImportance of viability and attachment to an ascites tumor in the release of plasminogen activatorPlatelet interaction with a pancreatic ascites tumor
P2860
Tumor interaction with hemostasis: the rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer.
description
1984 nî lūn-bûn
@nan
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
1984年论文
@zh
1984年论文
@zh-cn
name
Tumor interaction with hemosta ...... ts in the treatment of cancer.
@en
type
label
Tumor interaction with hemosta ...... ts in the treatment of cancer.
@en
prefLabel
Tumor interaction with hemosta ...... ts in the treatment of cancer.
@en
P2860
P356
P1476
Tumor interaction with hemosta ...... ts in the treatment of cancer.
@en
P2093
Al-Mondhiry H
P2860
P304
P356
10.1002/AJH.2830160213
P577
1984-02-01T00:00:00Z